HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of fibrinolysis during reperfusion of ischemic skeletal muscle.

Abstract
Skeletal muscle is unique in its ability to tolerate relatively long periods of ischemia without demonstrable damage following reperfusion. Prolonged ischemia, however, has been associated with muscle necrosis and poor recovery of function. Using a rabbit model of hind limb ischemia, periods of ischemia of 1, 2, 3, and 5 hours were studied. Whereas almost complete recovery was seen after 1 or 2 hours of ischemia, a progressive loss of function is seen with increasing ischemic interval. In addition, within the 5 hour group, up to 40% of preparations did not recover function during reperfusion, with no Doppler signals audible over the pedicle. In these, microscopic thrombi was demonstrated histologically. Thus it appears that the "no reflow" phenomenon plays a major role after prolonged (greater than 4 hrs) ischemia. In order to evaluate the effect of fibrinolytic drugs on the "no reflow" phenomenon, urokinase was infused prior to reperfusion, and after 5 hours of ischemia, in a separate group of animals. All of these reperfused without any evidence of "no reflow". We conclude that reperfusion injury may have two major components: the "no reflow" phenomenon secondary to poor reperfusion, and cellular injury resulting from reperfusion itself. Infusion of fibrinolytic agents during the initial phases of reperfusion may have a salutory effect in preventing the "no reflow" phenomenon. It is likely, however, that attempts at effective and safe retrieval of ischemic tissue will necessarily have to address both mechanisms.
AuthorsW J Quiñones-Baldrich
JournalMicrocirculation, endothelium, and lymphatics (Microcirc Endothelium Lymphatics) 1989 Jun-Oct Vol. 5 Issue 3-5 Pg. 299-314 ISSN: 0740-9451 [Print] United States
PMID2637946 (Publication Type: Journal Article)
Chemical References
  • Fibrinolytic Agents
Topics
  • Animals
  • Fibrinolysis
  • Fibrinolytic Agents (pharmacology, therapeutic use)
  • Hindlimb (blood supply)
  • Ischemia (physiopathology)
  • Muscles (blood supply, pathology)
  • Necrosis
  • Rabbits
  • Regional Blood Flow (drug effects)
  • Reperfusion
  • Reperfusion Injury (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: